Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule

• Main Authors: Antonella Chillemi (Author), Gianluca Zaccarello (Author), Valeria Quarona (Author), Manuela Ferracin (Author), Chiara Ghimenti (Author), Massimo Massaia (Author), Alberto L. Horenstein (Author), Fabio Malavasi (Author)
• Format: Book
• Published: BMC, 2013-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract In vivo use of monoclonal antibodies (mAbs) has become a mainstay of routine clinical practice in the treatment of various human diseases. A number of molecules can serve as targets, according to the condition being treated. Now entering human clinical trials, CD38 molecule is a particularl...